Duration of Payments. The amounts payable to BioLineRx under Section 4.2 shall be paid on a Product-by-Product and country-by-country basis until the expiration of the Royalty Term for such Product in such country.
Appears in 8 contracts
Sources: License and Commercialization Agreement (Bellerophon Therapeutics, Inc.), License and Commercialization Agreement (BioLineRx Ltd.), License and Commercialization Agreement (Bellerophon Therapeutics LLC)